The global market for Antibody-drug Conjugate (ADC) Payload was valued at US$ 1762 million in the year 2024 and is projected to reach a revised size of US$ 2988 million by 2031, growing at a CAGR of 8.5% during the forecast period.

Antibody-drug Conjugate (ADC) Payload Market

Antibody-drug Conjugate (ADC) Payload refers to a cytotoxic drug or bioactive molecule that is bound to an antibody. This payload is a key component of the ADC and is responsible for exerting an anti-tumor effect in the target cell to achieve a therapeutic effect. The design and selection of the payload directly affects the therapeutic effect and safety of the ADC and is an important part of achieving targeted therapy.

North American market for Antibody-drug Conjugate (ADC) Payload is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Antibody-drug Conjugate (ADC) Payload is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Antibody-drug Conjugate (ADC) Payload include Lonza, Veranova, Merck, Cerbios-Pharma SA, Porton Pharma Solutions, Ajinomoto Bio-Pharma, Teva Pharmaceutical Industries Ltd., Abzena, Sterling Pharma Solutions Limited, Indena, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antibody-drug Conjugate (ADC) Payload, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody-drug Conjugate (ADC) Payload.

The Antibody-drug Conjugate (ADC) Payload market size, estimations, and forecasts are provided in terms of sales volume (kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antibody-drug Conjugate (ADC) Payload market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Antibody-drug Conjugate (ADC) Payload manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Antibody-drug Conjugate (ADC) Payload Market Report

Report Metric	Details
Report Name	Antibody-drug Conjugate (ADC) Payload Market
Accounted market size in year	US$ 1762 million
Forecasted market size in 2031	US$ 2988 million
CAGR	8.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Tumor Specificity Broadly Targeted
Segment by Application	Pharmaceuticals Scientific Research
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Lonza, Veranova, Merck, Cerbios-Pharma SA, Porton Pharma Solutions, Ajinomoto Bio-Pharma, Teva Pharmaceutical Industries Ltd., Abzena, Sterling Pharma Solutions Limited, Indena, Pfizer, CordenPharma, Heraeus Precious Metals, Novasep, Shanghai Haoyuan Chemexpress Co. Ltd., Minakem
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antibody-drug Conjugate (ADC) Payload manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antibody-drug Conjugate (ADC) Payload in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Antibody-drug Conjugate (ADC) Payload Market growing?

Ans: The Antibody-drug Conjugate (ADC) Payload Market witnessing a CAGR of 8.5% during the forecast period 2025-2031.

What is the Antibody-drug Conjugate (ADC) Payload Market size in 2031?

Ans: The Antibody-drug Conjugate (ADC) Payload Market size in 2031 will be US$ 2988 million.

Who are the main players in the Antibody-drug Conjugate (ADC) Payload Market report?

Ans: The main players in the Antibody-drug Conjugate (ADC) Payload Market are Lonza, Veranova, Merck, Cerbios-Pharma SA, Porton Pharma Solutions, Ajinomoto Bio-Pharma, Teva Pharmaceutical Industries Ltd., Abzena, Sterling Pharma Solutions Limited, Indena, Pfizer, CordenPharma, Heraeus Precious Metals, Novasep, Shanghai Haoyuan Chemexpress Co. Ltd., Minakem

What are the Application segmentation covered in the Antibody-drug Conjugate (ADC) Payload Market report?

Ans: The Applications covered in the Antibody-drug Conjugate (ADC) Payload Market report are Pharmaceuticals, Scientific Research

What are the Type segmentation covered in the Antibody-drug Conjugate (ADC) Payload Market report?

Ans: The Types covered in the Antibody-drug Conjugate (ADC) Payload Market report are Tumor Specificity, Broadly Targeted

1 Antibody-drug Conjugate (ADC) Payload Market Overview

1.1 Product Definition

1.2 Antibody-drug Conjugate (ADC) Payload by Type

1.2.1 Global Antibody-drug Conjugate (ADC) Payload Market Value Comparison by Type (2024 VS 2031)

1.2.2 Tumor Specificity

1.2.3 Broadly Targeted

1.3 Antibody-drug Conjugate (ADC) Payload by Application

1.3.1 Global Antibody-drug Conjugate (ADC) Payload Market Value by Application (2024 VS 2031)

1.3.2 Pharmaceuticals

1.3.3 Scientific Research

1.4 Global Antibody-drug Conjugate (ADC) Payload Market Size Estimates and Forecasts

1.4.1 Global Antibody-drug Conjugate (ADC) Payload Revenue 2020-2031

1.4.2 Global Antibody-drug Conjugate (ADC) Payload Sales 2020-2031

1.4.3 Global Antibody-drug Conjugate (ADC) Payload Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Antibody-drug Conjugate (ADC) Payload Market Competition by Manufacturers

2.1 Global Antibody-drug Conjugate (ADC) Payload Sales Market Share by Manufacturers (2020-2025)

2.2 Global Antibody-drug Conjugate (ADC) Payload Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Antibody-drug Conjugate (ADC) Payload Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Antibody-drug Conjugate (ADC) Payload, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Antibody-drug Conjugate (ADC) Payload, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Antibody-drug Conjugate (ADC) Payload, Product Type & Application

2.7 Global Key Manufacturers of Antibody-drug Conjugate (ADC) Payload, Date of Enter into This Industry

2.8 Global Antibody-drug Conjugate (ADC) Payload Market Competitive Situation and Trends

2.8.1 Global Antibody-drug Conjugate (ADC) Payload Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Antibody-drug Conjugate (ADC) Payload Players Market Share by Revenue

2.8.3 Global Antibody-drug Conjugate (ADC) Payload Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Antibody-drug Conjugate (ADC) Payload Market Scenario by Region

3.1 Global Antibody-drug Conjugate (ADC) Payload Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Antibody-drug Conjugate (ADC) Payload Sales by Region: 2020-2031

3.2.1 Global Antibody-drug Conjugate (ADC) Payload Sales by Region: 2020-2025

3.2.2 Global Antibody-drug Conjugate (ADC) Payload Sales by Region: 2026-2031

3.3 Global Antibody-drug Conjugate (ADC) Payload Revenue by Region: 2020-2031

3.3.1 Global Antibody-drug Conjugate (ADC) Payload Revenue by Region: 2020-2025

3.3.2 Global Antibody-drug Conjugate (ADC) Payload Revenue by Region: 2026-2031

3.4 North America Antibody-drug Conjugate (ADC) Payload Market Facts & Figures by Country

3.4.1 North America Antibody-drug Conjugate (ADC) Payload Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Antibody-drug Conjugate (ADC) Payload Sales by Country (2020-2031)

3.4.3 North America Antibody-drug Conjugate (ADC) Payload Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Antibody-drug Conjugate (ADC) Payload Market Facts & Figures by Country

3.5.1 Europe Antibody-drug Conjugate (ADC) Payload Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Antibody-drug Conjugate (ADC) Payload Sales by Country (2020-2031)

3.5.3 Europe Antibody-drug Conjugate (ADC) Payload Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Antibody-drug Conjugate (ADC) Payload Market Facts & Figures by Region

3.6.1 Asia Pacific Antibody-drug Conjugate (ADC) Payload Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Antibody-drug Conjugate (ADC) Payload Sales by Region (2020-2031)

3.6.3 Asia Pacific Antibody-drug Conjugate (ADC) Payload Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Antibody-drug Conjugate (ADC) Payload Market Facts & Figures by Country

3.7.1 Latin America Antibody-drug Conjugate (ADC) Payload Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Antibody-drug Conjugate (ADC) Payload Sales by Country (2020-2031)

3.7.3 Latin America Antibody-drug Conjugate (ADC) Payload Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Antibody-drug Conjugate (ADC) Payload Market Facts & Figures by Country

3.8.1 Middle East and Africa Antibody-drug Conjugate (ADC) Payload Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Antibody-drug Conjugate (ADC) Payload Sales by Country (2020-2031)

3.8.3 Middle East and Africa Antibody-drug Conjugate (ADC) Payload Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Antibody-drug Conjugate (ADC) Payload Sales by Type (2020-2031)

4.1.1 Global Antibody-drug Conjugate (ADC) Payload Sales by Type (2020-2025)

4.1.2 Global Antibody-drug Conjugate (ADC) Payload Sales by Type (2026-2031)

4.1.3 Global Antibody-drug Conjugate (ADC) Payload Sales Market Share by Type (2020-2031)

4.2 Global Antibody-drug Conjugate (ADC) Payload Revenue by Type (2020-2031)

4.2.1 Global Antibody-drug Conjugate (ADC) Payload Revenue by Type (2020-2025)

4.2.2 Global Antibody-drug Conjugate (ADC) Payload Revenue by Type (2026-2031)

4.2.3 Global Antibody-drug Conjugate (ADC) Payload Revenue Market Share by Type (2020-2031)

4.3 Global Antibody-drug Conjugate (ADC) Payload Price by Type (2020-2031)

5 Segment by Application

5.1 Global Antibody-drug Conjugate (ADC) Payload Sales by Application (2020-2031)

5.1.1 Global Antibody-drug Conjugate (ADC) Payload Sales by Application (2020-2025)

5.1.2 Global Antibody-drug Conjugate (ADC) Payload Sales by Application (2026-2031)

5.1.3 Global Antibody-drug Conjugate (ADC) Payload Sales Market Share by Application (2020-2031)

5.2 Global Antibody-drug Conjugate (ADC) Payload Revenue by Application (2020-2031)

5.2.1 Global Antibody-drug Conjugate (ADC) Payload Revenue by Application (2020-2025)

5.2.2 Global Antibody-drug Conjugate (ADC) Payload Revenue by Application (2026-2031)

5.2.3 Global Antibody-drug Conjugate (ADC) Payload Revenue Market Share by Application (2020-2031)

5.3 Global Antibody-drug Conjugate (ADC) Payload Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Lonza

6.1.1 Lonza Company Information

6.1.2 Lonza Description and Business Overview

6.1.3 Lonza Antibody-drug Conjugate (ADC) Payload Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Lonza Antibody-drug Conjugate (ADC) Payload Product Portfolio

6.1.5 Lonza Recent Developments/Updates

6.2 Veranova

6.2.1 Veranova Company Information

6.2.2 Veranova Description and Business Overview

6.2.3 Veranova Antibody-drug Conjugate (ADC) Payload Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Veranova Antibody-drug Conjugate (ADC) Payload Product Portfolio

6.2.5 Veranova Recent Developments/Updates

6.3 Merck

6.3.1 Merck Company Information

6.3.2 Merck Description and Business Overview

6.3.3 Merck Antibody-drug Conjugate (ADC) Payload Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Merck Antibody-drug Conjugate (ADC) Payload Product Portfolio

6.3.5 Merck Recent Developments/Updates

6.4 Cerbios-Pharma SA

6.4.1 Cerbios-Pharma SA Company Information

6.4.2 Cerbios-Pharma SA Description and Business Overview

6.4.3 Cerbios-Pharma SA Antibody-drug Conjugate (ADC) Payload Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Cerbios-Pharma SA Antibody-drug Conjugate (ADC) Payload Product Portfolio

6.4.5 Cerbios-Pharma SA Recent Developments/Updates

6.5 Porton Pharma Solutions

6.5.1 Porton Pharma Solutions Company Information

6.5.2 Porton Pharma Solutions Description and Business Overview

6.5.3 Porton Pharma Solutions Antibody-drug Conjugate (ADC) Payload Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Porton Pharma Solutions Antibody-drug Conjugate (ADC) Payload Product Portfolio

6.5.5 Porton Pharma Solutions Recent Developments/Updates

6.6 Ajinomoto Bio-Pharma

6.6.1 Ajinomoto Bio-Pharma Company Information

6.6.2 Ajinomoto Bio-Pharma Description and Business Overview

6.6.3 Ajinomoto Bio-Pharma Antibody-drug Conjugate (ADC) Payload Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Ajinomoto Bio-Pharma Antibody-drug Conjugate (ADC) Payload Product Portfolio

6.6.5 Ajinomoto Bio-Pharma Recent Developments/Updates

6.7 Teva Pharmaceutical Industries Ltd.

6.7.1 Teva Pharmaceutical Industries Ltd. Company Information

6.7.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview

6.7.3 Teva Pharmaceutical Industries Ltd. Antibody-drug Conjugate (ADC) Payload Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Teva Pharmaceutical Industries Ltd. Antibody-drug Conjugate (ADC) Payload Product Portfolio

6.7.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates

6.8 Abzena

6.8.1 Abzena Company Information

6.8.2 Abzena Description and Business Overview

6.8.3 Abzena Antibody-drug Conjugate (ADC) Payload Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Abzena Antibody-drug Conjugate (ADC) Payload Product Portfolio

6.8.5 Abzena Recent Developments/Updates

6.9 Sterling Pharma Solutions Limited

6.9.1 Sterling Pharma Solutions Limited Company Information

6.9.2 Sterling Pharma Solutions Limited Description and Business Overview

6.9.3 Sterling Pharma Solutions Limited Antibody-drug Conjugate (ADC) Payload Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Sterling Pharma Solutions Limited Antibody-drug Conjugate (ADC) Payload Product Portfolio

6.9.5 Sterling Pharma Solutions Limited Recent Developments/Updates

6.10 Indena

6.10.1 Indena Company Information

6.10.2 Indena Description and Business Overview

6.10.3 Indena Antibody-drug Conjugate (ADC) Payload Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Indena Antibody-drug Conjugate (ADC) Payload Product Portfolio

6.10.5 Indena Recent Developments/Updates

6.11 Pfizer

6.11.1 Pfizer Company Information

6.11.2 Pfizer Description and Business Overview

6.11.3 Pfizer Antibody-drug Conjugate (ADC) Payload Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Pfizer Antibody-drug Conjugate (ADC) Payload Product Portfolio

6.11.5 Pfizer Recent Developments/Updates

6.12 CordenPharma

6.12.1 CordenPharma Company Information

6.12.2 CordenPharma Description and Business Overview

6.12.3 CordenPharma Antibody-drug Conjugate (ADC) Payload Sales, Revenue and Gross Margin (2020-2025)

6.12.4 CordenPharma Antibody-drug Conjugate (ADC) Payload Product Portfolio

6.12.5 CordenPharma Recent Developments/Updates

6.13 Heraeus Precious Metals

6.13.1 Heraeus Precious Metals Company Information

6.13.2 Heraeus Precious Metals Description and Business Overview

6.13.3 Heraeus Precious Metals Antibody-drug Conjugate (ADC) Payload Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Heraeus Precious Metals Antibody-drug Conjugate (ADC) Payload Product Portfolio

6.13.5 Heraeus Precious Metals Recent Developments/Updates

6.14 Novasep

6.14.1 Novasep Company Information

6.14.2 Novasep Description and Business Overview

6.14.3 Novasep Antibody-drug Conjugate (ADC) Payload Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Novasep Antibody-drug Conjugate (ADC) Payload Product Portfolio

6.14.5 Novasep Recent Developments/Updates

6.15 Shanghai Haoyuan Chemexpress Co. Ltd.

6.15.1 Shanghai Haoyuan Chemexpress Co. Ltd. Company Information

6.15.2 Shanghai Haoyuan Chemexpress Co. Ltd. Description and Business Overview

6.15.3 Shanghai Haoyuan Chemexpress Co. Ltd. Antibody-drug Conjugate (ADC) Payload Sales, Revenue and Gross Margin (2020-2025)

6.15.4 Shanghai Haoyuan Chemexpress Co. Ltd. Antibody-drug Conjugate (ADC) Payload Product Portfolio

6.15.5 Shanghai Haoyuan Chemexpress Co. Ltd. Recent Developments/Updates

6.16 Minakem

6.16.1 Minakem Company Information

6.16.2 Minakem Description and Business Overview

6.16.3 Minakem Antibody-drug Conjugate (ADC) Payload Sales, Revenue and Gross Margin (2020-2025)

6.16.4 Minakem Antibody-drug Conjugate (ADC) Payload Product Portfolio

6.16.5 Minakem Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Antibody-drug Conjugate (ADC) Payload Industry Chain Analysis

7.2 Antibody-drug Conjugate (ADC) Payload Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Antibody-drug Conjugate (ADC) Payload Production Mode & Process Analysis

7.4 Antibody-drug Conjugate (ADC) Payload Sales and Marketing

7.4.1 Antibody-drug Conjugate (ADC) Payload Sales Channels

7.4.2 Antibody-drug Conjugate (ADC) Payload Distributors

7.5 Antibody-drug Conjugate (ADC) Payload Customer Analysis

8 Antibody-drug Conjugate (ADC) Payload Market Dynamics

8.1 Antibody-drug Conjugate (ADC) Payload Industry Trends

8.2 Antibody-drug Conjugate (ADC) Payload Market Drivers

8.3 Antibody-drug Conjugate (ADC) Payload Market Challenges

8.4 Antibody-drug Conjugate (ADC) Payload Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Porton Pharma Solutions

Ajinomoto Bio-Pharma

Teva Pharmaceutical Industries Ltd

Heraeus Precious Metals

Novasep

Shanghai Haoyuan Chemexpress Co., Ltd

Minakem

Sterling Pharma Solutions Limited

List of Tables

Table 1. Global Antibody-drug Conjugate (ADC) Payload Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Antibody-drug Conjugate (ADC) Payload Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Antibody-drug Conjugate (ADC) Payload Market Competitive Situation by Manufacturers in 2024

Table 4. Global Antibody-drug Conjugate (ADC) Payload Sales (kg) of Key Manufacturers (2020-2025)

Table 5. Global Antibody-drug Conjugate (ADC) Payload Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Antibody-drug Conjugate (ADC) Payload Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Antibody-drug Conjugate (ADC) Payload Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Antibody-drug Conjugate (ADC) Payload Average Price (US$/g) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Antibody-drug Conjugate (ADC) Payload, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Antibody-drug Conjugate (ADC) Payload, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Antibody-drug Conjugate (ADC) Payload, Product Type & Application

Table 12. Global Key Manufacturers of Antibody-drug Conjugate (ADC) Payload, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Antibody-drug Conjugate (ADC) Payload by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody-drug Conjugate (ADC) Payload as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Antibody-drug Conjugate (ADC) Payload Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Antibody-drug Conjugate (ADC) Payload Sales by Region (2020-2025) & (kg)

Table 18. Global Antibody-drug Conjugate (ADC) Payload Sales Market Share by Region (2020-2025)

Table 19. Global Antibody-drug Conjugate (ADC) Payload Sales by Region (2026-2031) & (kg)

Table 20. Global Antibody-drug Conjugate (ADC) Payload Sales Market Share by Region (2026-2031)

Table 21. Global Antibody-drug Conjugate (ADC) Payload Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Antibody-drug Conjugate (ADC) Payload Revenue Market Share by Region (2020-2025)

Table 23. Global Antibody-drug Conjugate (ADC) Payload Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Antibody-drug Conjugate (ADC) Payload Revenue Market Share by Region (2026-2031)

Table 25. North America Antibody-drug Conjugate (ADC) Payload Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Antibody-drug Conjugate (ADC) Payload Sales by Country (2020-2025) & (kg)

Table 27. North America Antibody-drug Conjugate (ADC) Payload Sales by Country (2026-2031) & (kg)

Table 28. North America Antibody-drug Conjugate (ADC) Payload Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Antibody-drug Conjugate (ADC) Payload Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Antibody-drug Conjugate (ADC) Payload Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Antibody-drug Conjugate (ADC) Payload Sales by Country (2020-2025) & (kg)

Table 32. Europe Antibody-drug Conjugate (ADC) Payload Sales by Country (2026-2031) & (kg)

Table 33. Europe Antibody-drug Conjugate (ADC) Payload Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Antibody-drug Conjugate (ADC) Payload Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Antibody-drug Conjugate (ADC) Payload Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Antibody-drug Conjugate (ADC) Payload Sales by Region (2020-2025) & (kg)

Table 37. Asia Pacific Antibody-drug Conjugate (ADC) Payload Sales by Region (2026-2031) & (kg)

Table 38. Asia Pacific Antibody-drug Conjugate (ADC) Payload Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Antibody-drug Conjugate (ADC) Payload Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Antibody-drug Conjugate (ADC) Payload Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Antibody-drug Conjugate (ADC) Payload Sales by Country (2020-2025) & (kg)

Table 42. Latin America Antibody-drug Conjugate (ADC) Payload Sales by Country (2026-2031) & (kg)

Table 43. Latin America Antibody-drug Conjugate (ADC) Payload Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Antibody-drug Conjugate (ADC) Payload Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Antibody-drug Conjugate (ADC) Payload Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Antibody-drug Conjugate (ADC) Payload Sales by Country (2020-2025) & (kg)

Table 47. Middle East and Africa Antibody-drug Conjugate (ADC) Payload Sales by Country (2026-2031) & (kg)

Table 48. Middle East and Africa Antibody-drug Conjugate (ADC) Payload Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Antibody-drug Conjugate (ADC) Payload Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Antibody-drug Conjugate (ADC) Payload Sales (kg) by Type (2020-2025)

Table 51. Global Antibody-drug Conjugate (ADC) Payload Sales (kg) by Type (2026-2031)

Table 52. Global Antibody-drug Conjugate (ADC) Payload Sales Market Share by Type (2020-2025)

Table 53. Global Antibody-drug Conjugate (ADC) Payload Sales Market Share by Type (2026-2031)

Table 54. Global Antibody-drug Conjugate (ADC) Payload Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Antibody-drug Conjugate (ADC) Payload Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Antibody-drug Conjugate (ADC) Payload Revenue Market Share by Type (2020-2025)

Table 57. Global Antibody-drug Conjugate (ADC) Payload Revenue Market Share by Type (2026-2031)

Table 58. Global Antibody-drug Conjugate (ADC) Payload Price (US$/g) by Type (2020-2025)

Table 59. Global Antibody-drug Conjugate (ADC) Payload Price (US$/g) by Type (2026-2031)

Table 60. Global Antibody-drug Conjugate (ADC) Payload Sales (kg) by Application (2020-2025)

Table 61. Global Antibody-drug Conjugate (ADC) Payload Sales (kg) by Application (2026-2031)

Table 62. Global Antibody-drug Conjugate (ADC) Payload Sales Market Share by Application (2020-2025)

Table 63. Global Antibody-drug Conjugate (ADC) Payload Sales Market Share by Application (2026-2031)

Table 64. Global Antibody-drug Conjugate (ADC) Payload Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Antibody-drug Conjugate (ADC) Payload Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Antibody-drug Conjugate (ADC) Payload Revenue Market Share by Application (2020-2025)

Table 67. Global Antibody-drug Conjugate (ADC) Payload Revenue Market Share by Application (2026-2031)

Table 68. Global Antibody-drug Conjugate (ADC) Payload Price (US$/g) by Application (2020-2025)

Table 69. Global Antibody-drug Conjugate (ADC) Payload Price (US$/g) by Application (2026-2031)

Table 70. Lonza Company Information

Table 71. Lonza Description and Business Overview

Table 72. Lonza Antibody-drug Conjugate (ADC) Payload Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 73. Lonza Antibody-drug Conjugate (ADC) Payload Product

Table 74. Lonza Recent Developments/Updates

Table 75. Veranova Company Information

Table 76. Veranova Description and Business Overview

Table 77. Veranova Antibody-drug Conjugate (ADC) Payload Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 78. Veranova Antibody-drug Conjugate (ADC) Payload Product

Table 79. Veranova Recent Developments/Updates

Table 80. Merck Company Information

Table 81. Merck Description and Business Overview

Table 82. Merck Antibody-drug Conjugate (ADC) Payload Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 83. Merck Antibody-drug Conjugate (ADC) Payload Product

Table 84. Merck Recent Developments/Updates

Table 85. Cerbios-Pharma SA Company Information

Table 86. Cerbios-Pharma SA Description and Business Overview

Table 87. Cerbios-Pharma SA Antibody-drug Conjugate (ADC) Payload Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 88. Cerbios-Pharma SA Antibody-drug Conjugate (ADC) Payload Product

Table 89. Cerbios-Pharma SA Recent Developments/Updates

Table 90. Porton Pharma Solutions Company Information

Table 91. Porton Pharma Solutions Description and Business Overview

Table 92. Porton Pharma Solutions Antibody-drug Conjugate (ADC) Payload Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 93. Porton Pharma Solutions Antibody-drug Conjugate (ADC) Payload Product

Table 94. Porton Pharma Solutions Recent Developments/Updates

Table 95. Ajinomoto Bio-Pharma Company Information

Table 96. Ajinomoto Bio-Pharma Description and Business Overview

Table 97. Ajinomoto Bio-Pharma Antibody-drug Conjugate (ADC) Payload Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 98. Ajinomoto Bio-Pharma Antibody-drug Conjugate (ADC) Payload Product

Table 99. Ajinomoto Bio-Pharma Recent Developments/Updates

Table 100. Teva Pharmaceutical Industries Ltd. Company Information

Table 101. Teva Pharmaceutical Industries Ltd. Description and Business Overview

Table 102. Teva Pharmaceutical Industries Ltd. Antibody-drug Conjugate (ADC) Payload Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 103. Teva Pharmaceutical Industries Ltd. Antibody-drug Conjugate (ADC) Payload Product

Table 104. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates

Table 105. Abzena Company Information

Table 106. Abzena Description and Business Overview

Table 107. Abzena Antibody-drug Conjugate (ADC) Payload Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 108. Abzena Antibody-drug Conjugate (ADC) Payload Product

Table 109. Abzena Recent Developments/Updates

Table 110. Sterling Pharma Solutions Limited Company Information

Table 111. Sterling Pharma Solutions Limited Description and Business Overview

Table 112. Sterling Pharma Solutions Limited Antibody-drug Conjugate (ADC) Payload Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 113. Sterling Pharma Solutions Limited Antibody-drug Conjugate (ADC) Payload Product

Table 114. Sterling Pharma Solutions Limited Recent Developments/Updates

Table 115. Indena Company Information

Table 116. Indena Description and Business Overview

Table 117. Indena Antibody-drug Conjugate (ADC) Payload Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 118. Indena Antibody-drug Conjugate (ADC) Payload Product

Table 119. Indena Recent Developments/Updates

Table 120. Pfizer Company Information

Table 121. Pfizer Description and Business Overview

Table 122. Pfizer Antibody-drug Conjugate (ADC) Payload Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 123. Pfizer Antibody-drug Conjugate (ADC) Payload Product

Table 124. Pfizer Recent Developments/Updates

Table 125. CordenPharma Company Information

Table 126. CordenPharma Description and Business Overview

Table 127. CordenPharma Antibody-drug Conjugate (ADC) Payload Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 128. CordenPharma Antibody-drug Conjugate (ADC) Payload Product

Table 129. CordenPharma Recent Developments/Updates

Table 130. Heraeus Precious Metals Company Information

Table 131. Heraeus Precious Metals Description and Business Overview

Table 132. Heraeus Precious Metals Antibody-drug Conjugate (ADC) Payload Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 133. Heraeus Precious Metals Antibody-drug Conjugate (ADC) Payload Product

Table 134. Heraeus Precious Metals Recent Developments/Updates

Table 135. Novasep Company Information

Table 136. Novasep Description and Business Overview

Table 137. Novasep Antibody-drug Conjugate (ADC) Payload Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 138. Novasep Antibody-drug Conjugate (ADC) Payload Product

Table 139. Novasep Recent Developments/Updates

Table 140. Shanghai Haoyuan Chemexpress Co. Ltd. Company Information

Table 141. Shanghai Haoyuan Chemexpress Co. Ltd. Description and Business Overview

Table 142. Shanghai Haoyuan Chemexpress Co. Ltd. Antibody-drug Conjugate (ADC) Payload Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 143. Shanghai Haoyuan Chemexpress Co. Ltd. Antibody-drug Conjugate (ADC) Payload Product

Table 144. Shanghai Haoyuan Chemexpress Co. Ltd. Recent Developments/Updates

Table 145. Minakem Company Information

Table 146. Minakem Description and Business Overview

Table 147. Minakem Antibody-drug Conjugate (ADC) Payload Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 148. Minakem Antibody-drug Conjugate (ADC) Payload Product

Table 149. Minakem Recent Developments/Updates

Table 150. Key Raw Materials Lists

Table 151. Raw Materials Key Suppliers Lists

Table 152. Antibody-drug Conjugate (ADC) Payload Distributors List

Table 153. Antibody-drug Conjugate (ADC) Payload Customers List

Table 154. Antibody-drug Conjugate (ADC) Payload Market Trends

Table 155. Antibody-drug Conjugate (ADC) Payload Market Drivers

Table 156. Antibody-drug Conjugate (ADC) Payload Market Challenges

Table 157. Antibody-drug Conjugate (ADC) Payload Market Restraints

Table 158. Research Programs/Design for This Report

Table 159. Key Data Information from Secondary Sources

Table 160. Key Data Information from Primary Sources

Table 161. Authors List of This Report

List of Figures

Figure 1. Product Picture of Antibody-drug Conjugate (ADC) Payload

Figure 2. Global Antibody-drug Conjugate (ADC) Payload Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Antibody-drug Conjugate (ADC) Payload Market Share by Type: 2024 & 2031

Figure 4. Tumor Specificity Product Picture

Figure 5. Broadly Targeted Product Picture

Figure 6. Global Antibody-drug Conjugate (ADC) Payload Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Antibody-drug Conjugate (ADC) Payload Market Share by Application: 2024 & 2031

Figure 8. Pharmaceuticals

Figure 9. Scientific Research

Figure 10. Global Antibody-drug Conjugate (ADC) Payload Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Antibody-drug Conjugate (ADC) Payload Market Size (2020-2031) & (US$ Million)

Figure 12. Global Antibody-drug Conjugate (ADC) Payload Sales (2020-2031) & (kg)

Figure 13. Global Antibody-drug Conjugate (ADC) Payload Average Price (US$/g) & (2020-2031)

Figure 14. Antibody-drug Conjugate (ADC) Payload Report Years Considered

Figure 15. Antibody-drug Conjugate (ADC) Payload Sales Share by Manufacturers in 2024

Figure 16. Global Antibody-drug Conjugate (ADC) Payload Revenue Share by Manufacturers in 2024

Figure 17. Global 5 and 10 Largest Antibody-drug Conjugate (ADC) Payload Players: Market Share by Revenue in Antibody-drug Conjugate (ADC) Payload in 2024

Figure 18. Antibody-drug Conjugate (ADC) Payload Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 19. Global Antibody-drug Conjugate (ADC) Payload Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 20. North America Antibody-drug Conjugate (ADC) Payload Sales Market Share by Country (2020-2031)

Figure 21. North America Antibody-drug Conjugate (ADC) Payload Revenue Market Share by Country (2020-2031)

Figure 22. United States Antibody-drug Conjugate (ADC) Payload Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 23. Canada Antibody-drug Conjugate (ADC) Payload Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Europe Antibody-drug Conjugate (ADC) Payload Sales Market Share by Country (2020-2031)

Figure 25. Europe Antibody-drug Conjugate (ADC) Payload Revenue Market Share by Country (2020-2031)

Figure 26. Germany Antibody-drug Conjugate (ADC) Payload Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. France Antibody-drug Conjugate (ADC) Payload Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. U.K. Antibody-drug Conjugate (ADC) Payload Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Italy Antibody-drug Conjugate (ADC) Payload Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Russia Antibody-drug Conjugate (ADC) Payload Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Asia Pacific Antibody-drug Conjugate (ADC) Payload Sales Market Share by Region (2020-2031)

Figure 32. Asia Pacific Antibody-drug Conjugate (ADC) Payload Revenue Market Share by Region (2020-2031)

Figure 33. China Antibody-drug Conjugate (ADC) Payload Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Japan Antibody-drug Conjugate (ADC) Payload Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. South Korea Antibody-drug Conjugate (ADC) Payload Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. India Antibody-drug Conjugate (ADC) Payload Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Australia Antibody-drug Conjugate (ADC) Payload Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. China Taiwan Antibody-drug Conjugate (ADC) Payload Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Southeast Asia Antibody-drug Conjugate (ADC) Payload Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Latin America Antibody-drug Conjugate (ADC) Payload Sales Market Share by Country (2020-2031)

Figure 41. Latin America Antibody-drug Conjugate (ADC) Payload Revenue Market Share by Country (2020-2031)

Figure 42. Mexico Antibody-drug Conjugate (ADC) Payload Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Brazil Antibody-drug Conjugate (ADC) Payload Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Argentina Antibody-drug Conjugate (ADC) Payload Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Colombia Antibody-drug Conjugate (ADC) Payload Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Middle East and Africa Antibody-drug Conjugate (ADC) Payload Sales Market Share by Country (2020-2031)

Figure 47. Middle East and Africa Antibody-drug Conjugate (ADC) Payload Revenue Market Share by Country (2020-2031)

Figure 48. Turkey Antibody-drug Conjugate (ADC) Payload Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Saudi Arabia Antibody-drug Conjugate (ADC) Payload Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. UAE Antibody-drug Conjugate (ADC) Payload Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Global Sales Market Share of Antibody-drug Conjugate (ADC) Payload by Type (2020-2031)

Figure 52. Global Revenue Market Share of Antibody-drug Conjugate (ADC) Payload by Type (2020-2031)

Figure 53. Global Antibody-drug Conjugate (ADC) Payload Price (US$/g) by Type (2020-2031)

Figure 54. Global Sales Market Share of Antibody-drug Conjugate (ADC) Payload by Application (2020-2031)

Figure 55. Global Revenue Market Share of Antibody-drug Conjugate (ADC) Payload by Application (2020-2031)

Figure 56. Global Antibody-drug Conjugate (ADC) Payload Price (US$/g) by Application (2020-2031)

Figure 57. Antibody-drug Conjugate (ADC) Payload Value Chain

Figure 58. Channels of Distribution (Direct Vs Distribution)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global First Aid Kits Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-2E758

Wed Feb 26 00:00:00 UTC 2025

Add to Cart

Global Coral Calcium Supplyments Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-38Y10038

Wed Feb 26 00:00:00 UTC 2025

Add to Cart

Global Antifungal and Ringworm Treatment Drugs Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-25M18710

Wed Feb 26 00:00:00 UTC 2025

Add to Cart

Global Menadione Sodium Bisulfite Injection Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-16V19032

Wed Feb 26 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions